Compound loss of GSDMD and GSDME function is necessary to achieve maximal therapeutic effect in colitis

Authors

Jianqiu Xiao, Washington University School of Medicine in St. Louis
Kai Sun, Washington University School of Medicine in St. Louis
Chun Wang, Washington University School of Medicine in St. Louis
Yousef Abu-Amer, Washington University School of Medicine in St. Louis
Gabriel Mbalaviele, Washington University School of Medicine in St. Louis

Journal

Journal of Translational Autoimmunity

Publication Date

1-1-2022

Volume

5

First Page

100162

Document Type

Open Access Publication

DOI

10.1016/j.jtauto.2022.100162

Rights and Permissions

Xiao J, Sun K, Wang C, Abu-Amer Y, Mbalaviele G. Compound loss of GSDMD and GSDME function is necessary to achieve maximal therapeutic effect in colitis. J Transl Autoimmun. 2022 Aug 30;5:100162. doi: 10.1016/j.jtauto.2022.100162. © 2022 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by- nc-nd/4.0/).

Recommended Citation

Xiao, Jianqiu; Sun, Kai; Wang, Chun; Abu-Amer, Yousef; and Mbalaviele, Gabriel, "Compound loss of GSDMD and GSDME function is necessary to achieve maximal therapeutic effect in colitis." Journal of Translational Autoimmunity. 5, 100162 (2022).
https://digitalcommons.wustl.edu/oa_4/1598

Department

ICTS (Institute of Clinical and Translational Sciences)